Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Queensland Health
Boehringer Ingelheim
Cipla
Teva
Chubb
Medtronic
QuintilesIMS

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020920

« Back to Dashboard

NDA 020920 describes NATRECOR, which is a drug marketed by Scios Llc and is included in one NDA. It is available from one supplier. Additional details are available on the NATRECOR profile page.

The generic ingredient in NATRECOR is nesiritide recombinant. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nesiritide recombinant profile page.
Summary for 020920
Tradename:NATRECOR
Applicant:Scios Llc
Ingredient:nesiritide recombinant
Patents:0
Pharmacology for NDA: 020920
Ingredient-typeNatriuretic Peptides
Suppliers and Packaging for NDA: 020920
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920 NDA Scios LLC 65847-205 65847-205-25 1 VIAL, SINGLE-USE in 1 CARTON (65847-205-25) > 5 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INTRAVENOUSStrength1.5MG/VIAL
Approval Date:Aug 10, 2001TE:RLD:Yes

Expired US Patents for NDA 020920

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Scios Llc NATRECOR nesiritide recombinant FOR SOLUTION;INTRAVENOUS 020920-001 Aug 10, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Healthtrust
Fish and Richardson
Julphar
Federal Trade Commission
Fuji
Cipla
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.